TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion apparatus, optimization, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts. Show More...
-
Website http://www.transmedics.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 127.12 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.66 -1.44 -17.48 -2.36 -1.66 Dividends USD Payout Ratio % * Shares Mil 14.0 14.0 1.0 14.0 21.0 Book Value Per Share * USD 3.0 2.19 Free Cash Flow Per Share * USD -1.49 Return on Assets % -56.28 -58.64 -45.5 -52.33 Financial Leverage (Average) 1.93 2.08 Return on Equity % -134.66 Return on Invested Capital % -49.64 Interest Coverage -23.58 -18.39 -7.72 -6.7 -7.24 Current Ratio 3.12 2.77 6.21 6.1 Quick Ratio 2.35 1.89 5.41 5.23 Debt/Equity 0.62 0.73